Publication | Open Access

Nifetepimine, a Dihydropyrimidone, Ensures CD4+ T Cell Survival in a Tumor Microenvironment by Maneuvering Sarco(endo)plasmic Reticulum Ca2+ ATPase (SERCA)

Tumor BiologyCancer ImmunosurveillanceImmunologyReticulum Ca2+ AtpaseTumor TargetingTumor SuppressorMedicineCell BiologyTumor MicroenvironmentCancer Research